Coherus Biosciences Inc (NASDAQ: CHRS) – Not A Clear Buying Opportunity?
Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $0.82, with 9.45 million shares of worth about $7.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.32% during that period and on November 07, 2024 the price saw a […]
Is There More Upside Ahead For Coherus Biosciences Inc (NASDAQ: CHRS)
Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $0.85, with 3.23 million shares of worth about $2.75 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -57.59% during that period and on October 17, 2024 the price saw a […]
Tomorrow Is Not Likely To Be Same For Coherus Biosciences Inc (CHRS)
Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $0.97, with 3.07 million shares of worth about $2.98 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -59.73% during that period and on October 10, 2024 the price saw a […]
Set Your Sights On Coherus Biosciences Inc (NASDAQ: CHRS)’S Upside Potential
Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $1.04, with 15.36 million shares of worth about $15.98 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -55.36% during that period and on October 03, 2024 the price saw a […]
Do Coherus Biosciences Inc (NASDAQ: CHRS) Fit In A Value Investing Philosophy?
Currently, there are 111.36M common shares owned by the public and among those 106.20M shares have been available to trade. Insiders at the company have transacted a total of 3 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
Is Coherus Biosciences Inc (NASDAQ: CHRS) Proving The Doubters Wrong?
Coherus Biosciences Inc (CHRS) concluded trading on Thursday at a closing price of $2.09, with 3.42 million shares of worth about $7.16 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -51.84% during that period and on Thursday, February 01 price saw a loss […]
Gains May Be On The Menu For Coherus Biosciences Inc (NASDAQ: CHRS)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Coherus Biosciences Inc (NASDAQ:CHRS). The institutional investor has increased its shareholding in the Healthcare company by 4.89% to 9.55 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 8.58% valued currently at $31.8 million. In addition, […]
Growing Through Challenges? – Coherus Biosciences Inc (CHRS)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Coherus Biosciences Inc (NASDAQ:CHRS). The institutional investor has increased its shareholding in the Healthcare company by 4.89% to 9.55 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 8.58% valued currently at $20.34 million. In addition, […]
Do Coherus Biosciences Inc (NASDAQ: CHRS) Fit In A Value Investing Philosophy?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Coherus Biosciences Inc (NASDAQ:CHRS). The institutional investor has increased its shareholding in the Healthcare company by 4.89% to 9.55 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 8.58% valued currently at $20.34 million. In addition, […]
Coherus Biosciences Inc (NASDAQ: CHRS) Hogging The Spotlight Today
With over 8.24 million Coherus Biosciences Inc (CHRS) shares trading Tuesday and a closing price of $2.18 on the day, the dollar volume was approximately $17.97 million. The shares have shown a negative half year performance of -43.23% and its price on 12/26/23 gained nearly 7.92%. Currently, there are 111.36M common shares owned by the […]
